JPMorgan Chase & Co’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.4K Sell
8,881
-21,304
-71% -$63.3K ﹤0.01% 5267
2025
Q1
$97.8K Buy
30,185
+15,561
+106% +$50.4K ﹤0.01% 4746
2024
Q4
$57.8K Buy
14,624
+5,930
+68% +$23.4K ﹤0.01% 4961
2024
Q3
$67.2K Buy
8,694
+770
+10% +$5.95K ﹤0.01% 4885
2024
Q2
$40.7K Buy
7,924
+7,886
+20,753% +$40.5K ﹤0.01% 4973
2024
Q1
$309 Hold
38
﹤0.01% 5757
2023
Q4
$152 Hold
38
﹤0.01% 6038
2023
Q3
$157 Hold
38
﹤0.01% 5908
2023
Q2
$226 Hold
38
﹤0.01% 5714
2023
Q1
$0 Hold
38
﹤0.01% 6144
2022
Q4
$0 Sell
38
-11,098
-100% ﹤0.01% 5965
2022
Q3
$40K Sell
11,136
-3,672
-25% -$13.2K ﹤0.01% 4766
2022
Q2
$83K Sell
14,808
-285
-2% -$1.6K ﹤0.01% 4706
2022
Q1
$131K Buy
15,093
+6,360
+73% +$55.2K ﹤0.01% 4635
2021
Q4
$98K Buy
8,733
+616
+8% +$6.91K ﹤0.01% 4842
2021
Q3
$105K Sell
8,117
-6,222
-43% -$80.5K ﹤0.01% 4687
2021
Q2
$238K Sell
14,339
-11,164
-44% -$185K ﹤0.01% 4409
2021
Q1
$438K Buy
25,503
+19,065
+296% +$327K ﹤0.01% 4106
2020
Q4
$100K Buy
6,438
+1,118
+21% +$17.4K ﹤0.01% 4301
2020
Q3
$101K Buy
5,320
+476
+10% +$9.04K ﹤0.01% 4045
2020
Q2
$67K Buy
4,844
+567
+13% +$7.84K ﹤0.01% 4110
2020
Q1
$46K Sell
4,277
-1,980
-32% -$21.3K ﹤0.01% 4163
2019
Q4
$117K Buy
6,257
+37
+0.6% +$692 ﹤0.01% 3971
2019
Q3
$65K Buy
6,220
+1,631
+36% +$17K ﹤0.01% 4143
2019
Q2
$34K Buy
+4,589
New +$34K ﹤0.01% 4395
2018
Q2
Sell
-3,890
Closed -$21K 4860
2018
Q1
$21K Sell
3,890
-279
-7% -$1.51K ﹤0.01% 4405
2017
Q4
$16K Buy
+4,169
New +$16K ﹤0.01% 4429
2017
Q2
Sell
-24,840
Closed -$410K 4536
2017
Q1
$410K Buy
24,840
+21,616
+670% +$357K ﹤0.01% 3232
2016
Q4
$33K Sell
3,224
-1,903
-37% -$19.5K ﹤0.01% 4083
2016
Q3
$69K Buy
5,127
+4,902
+2,179% +$66K ﹤0.01% 3516
2016
Q2
$5K Buy
+225
New +$5K ﹤0.01% 3947